Ethmoidal polyposis (EP) is a frequent form of chronic rhinosinusitis. Medical therapy is the main modality of treatment. Non responders to medical treatment require surgical removal of polyps by Endoscopic Sinus Surgery (ESS). Many studies showed worsening of the lung function following ESS whereas few studies showed improvement in the symptoms and better quality of life. Hence this study is an attempt to assess the effect of ethmoidal polyps on the pulmonary function and also the change in the lung function in the patients with ethmoidal polyps post ESS. Methods: A prospective observational study was conducted in a tertiary care hospital on 50 subjects with ethmoidal polyposis who were unresponsive to medical treatment and hence underwent ESS. Pulmonary function tests were assessed using spirometry and nasal symptoms were scored as per TNSS system prior to surgery and 3 months post surgery and compared with the pre op values and analysed. Results: There were 30 males and 20 females with majority of them in the age group of 41-50 yrs. The mean pre op FVC, FEV1, MEFR were 2.94liters, 2.41 liters and 2.51 liters respectively whereas the mean post operative values were 2.95 liters, 2.39 liters and 2.49 liters respectively.. The ratio of FEV1 and FVC was more than 0.7 in 98 % patients pre operatively and 94% post operatively. There was no statistically significant change in lung function tests following ESS. Pre operatively majority (35) had TNSS value between 6-9 where as post operatively the score was reduced to 2-3 in many patients (38). The mean TNSS was 7.24 before surgery which declined to 2.82 after surgery with a p value <0.0001indicating a statistically significant improvement in the nasal symptoms post ESS. Conclusion: Our study shows that ESS benefits patients with nasal polyps by improving the symptoms and there by the quality of life without any adverse effects on the lower airways.
Introduction
Ethmoidal polyposis (EP) is a form of chronic rhino-sinusitis, always arise from the lateral wall of nose, usually from the middle meatus. Aetiology of nasal polypi is very complex and may arise in inflammatory conditions of nasal mucosa (rhinosinusitis), disorders of ciliary motility or abnormal composition of nasal mucus (cystic fibrosis). Persistence of infection causes mucosal changes, such as loss of cilia, oedema and polyp formation, thus continuing the vicious cycle in the pathology chronic rhino sinusitis 1 . EP cause persistent nasal obstruction, hyposmia, infection, hypoxia, hypercapnia, snoring, sleep http://jmscr.igmpublication.org/home/ ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i9.123 disorders, increased risk of hypertension and impaired quality of life 2 . Various mechanisms have been proposed to explain how rhinosinusitis may affect the lower airways. Some of them are aspiration of infected sinus secretions into the lower airways during sleep, enhanced vagal stimulation in the infected sinus producing bronchospasm and excessive drying of the lower airways by mouth breathing because of nasal obstruction 2, 3 . Treatment of EP consists of medical therapy with intranasal steroids or a short course of systemic steroids, antibiotics, leukotriene modifiers, mast cell stabilizers and acetylsalicylic acid avoidance 3 . Subjects who do not respond to topical steroids require Functional Endoscopic Sinus Surgery which aims to restore normal nasal function, mucociliary clearance and promotes sinus ventilation and sinus drainage.
Rationale of Study
The benefits after surgery in relation with the pulmonary function is a debate. Certain studies like Lamblin C et al 4 and Van der Veer et al 5 reported that the patients who did not respond to medical treatment exhibited a significant decrease of FEV1 and FEV1/FVC ratio post-surgery. Whereas, studies by YoungjinAhn 6 et al, and colleaguesshowed no significant change in the bronchial hyperactivity and other studies by, Gillian Dunlop et al 7 , Marleen Vleming 8 showed improvement in the lung parameters post surgery for ethmoidal polyps. So the present study aimed at benefits of endoscopic surgery in cases of ethmoidal polyp in terms of nasal symptoms and pulmonary function in the present setting.
Aims and Objectives
The main aim of this study is to assess the pulmonary function in patients with Ethmoidal polyposis who did not respond to medical treatment and to evaluate the effect of endoscopic sinus surgery on the lung function in these patients. Inclusion Criteria: Patients of all age groups who were diagnosed endoscopically with bilateral ethmoidal polyps and who were -unresponsive to medical treatment (oral steroids for 1 week, broad spectrum antibiotics for 1-2 weeks, antihistamines for 1 month, steroid nasal spray for 1 month and saline nasal irrigation) for 1 month were subjected to ESS. Exclusion Criteria:-Patients with h/o nasal surgery, pulmonary symptoms and lung pathology not attributed to allergy and asthma like COPD, pneumonia/lung abscess, ciliary dyskinesia syndromes etc. and patients lost to follow up were excluded from the study.
Material and Methods

Study Setting
The 4 point total nasal symptom scoring (TNSS) and the pulmonary function tests which include FVC, FEV1, MEFR were done 48 hours prior to surgery and 3 months post operatively and were compared. Forced vital capacity (FVC) is the volume change of the lung between a full inspiration to total lung capacity and a maximal expiration to residual volume 9 . Forced expiratory volume in first second (FEV1) is the volume exhaled during the first second of a forced expiratory manoeuvre started from the level of total lung capacity. The FEV1/FVC ratio, also called Tiffeneau-Pinelli index represents the proportion of a person's vital capacity that they are able to expire in the first second. Maximum mid expiratory flow rate (MEFR) is the forced expiratory flow between 25% and 75% of the FVC (FEF25-75%). The MEFR is also used as an index of airway obstruction 9, 10, 11 . These lung function tests are assessed by spirometry and compared with the predetermined value based on the patient's age, sex and BMI and the degree of derangement is calculated as mild, moderate, severe and very severe (table I) 9, 10, 11 . TNSS is a 12-point scale derived by summing and averaging all scores for four symptoms: Rhinorrhea, nasal obstruction, sneezing, and nasal itching. Each symptom is given a score -0 (none), 1 (mild), 2 (moderate) or 3 (severe) -resulting in a maximum recorded mean TNSS of 12 (table II) . The scoring is done by the patients depending on the frequency of the symptoms and interference with daily activity. Noneno symptom, mildsymptom present but was not annoying or troublesome, moderate -symptom frequently troublesome but does not interfere with either routine daily activity or sleep, severe -symptom was sufficiently troublesome to have interfered with routine daily activity or sleep based on patients' assessment of severity 12 . Data Collection Technique: Data was collected from the semi structured proforma sheets and spirometry charts. Data was entered in MS-excel 2007 and data was analysed using SPSS software trail version 22. The results were assessed with a paired student -T test and the p-value was calculated for the FVC, FEV1, MEFR and TNSS (total nasal symptom scoring). p<0.05 is considered as statistical significance. Ethical Clearance: A clearance from the institutional ethics committee was obtained for carrying out this study. Informed consent was taken from the patients. Conflict of Interest: There was No conflict of interest in this study. No funding or support was taken from any organization.
Observations and Results
Age & Sex: 50 patients were taken for the study of which 60% (30) were males and 40% (20) were females. Majority were in the age group of 41-50 yrs -32% (16) with the least being in the age group of >60 yrs 4% (2) . Symptoms Pre operatively majority of patients, that is 36 had mild and moderate degree of rhinorrhea, 11 had severe rhinorrhea (total n=47) and 3 did not have the symptom at all. Post operatively 26 people did not have the symptom, 24 patients had mild and moderate degree of rhinorrhea. Whereas none of the patients had severe rhinorrhea ( (Table. No.1). The difference between the distribution of all symptoms pre and post op were found to be statistically significant.
TNSS scoring
Preoperatively the mean symptom scoring of all the 50 patients was 7.24 and the postoperative mean score was 2.82 with a difference of 4.42. The standard deviation was 3.017 and p value calculated for these mean pre and post operative total TNSS systems was <0.0001 which is statistically significant. (table V) . The mean preoperative MEFR was 2.5182 lit/sec and the mean postoperative value is 2.4988 lit/sec with a difference of 0.01940 and mean difference in standard deviation is 0.43926. The p value is 0.756 (Table no. 2). The ratio of FEV1 and FVC was more than 0.7 in 98 % patients pre operatively and 94% post operatively. 
Discussion
Many studies have been done previously which showed either a subjective or objective worsening/ improvement/no change in the lung functions and nasal symptoms in patients who underwent FESS for ethmoidal polyposis. But no definite conclusions have been made whether the surgery has any impact on the lower respiratory tract and quality of life on a long term basis. This study is an attempt to supplement data for coming to a conclusion regarding the surgical treatment of the nasal polyposis. Our study is based on objective evaluation of the lung volumes and subjective assessment of the nasal symptoms in patients with ethmoidal polyposis. 50 non-responder patients were taken into the study. The lung function tests and nasal symptoms scoring were done preoperatively and 3months post operatively, compared and analyzed. Agee and Sex: Male predominance is seen in the present study (Male to female ratio is 1 
Conclusions
This study is intended to assess the pulmonary function in patients with ethmoidal polyposis who did not respond to medical treatment and to evaluate the effect of endoscopic sinus surgery on the lung function and nasal symptoms in these patients. There is a significant clinical improvement in the nasal symptoms (p value of TNSS-<0.0001) of the subjects taken into the study, post ESS and medical treatment as depicted by the TNSS system. However, there was no statistically significant change in the pulmonary function tests as all the three values FVC, FEV1, MEFR had p value far more than 0.05(0.859, 0.697, 0.756 respectively). This concludes that ESS benefits the patients with nasal polyps who did not respond to medical treatment by improving the symptoms and there by the quality of life without any adverse effects on the lower airways.
Recommendation
As this study has used plain PFT without causing any broncho-provocation via methacholine/ carbachol challenge and also a small nasal symptom scoring system-TNSS and had only limited follow up period -3 month and small size. Hence further elaborative studies with large sample size and longer follow up periods are recommended to evaluate the effect of ESS on lower airway in nasal polyps patients.
